# Gionata Fiorino

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gionata-fiorino/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,535 |
| Field | Inflammatory Bowel Disease |
| h-index | 68 |
| i10-index | 234 |
| Last Known Institution | Azienda Ospedaliera San Camillo-Forlanini |
| OpenAlex ID | https://openalex.org/A5014483659 |
| ORCID iD | https://orcid.org/0000-0001-5623-2968 |
| Works | 553 |

## Researcher papers

- [Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target](https://scholariq.org/papers/selecting-therapeutic-targets-in-inflammatory-bowel-disease-stride-determining/)
- [ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications](https://scholariq.org/papers/ecco-esgar-guideline-for-diagnostic-assessment-in-ibd-part-1-initial-diagnosis/)
- [ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-surgical-treatment/)
- [ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-medical-treatment/)
- [ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-surgical-treatment/)
- [ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects](https://scholariq.org/papers/ecco-esgar-guideline-for-diagnostic-assessment-in-ibd-part-2-ibd-scores-and/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment-2/)
- [Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study](https://scholariq.org/papers/outcomes-of-covid-19-in-79-patients-with-ibd-in-italy-an-ig-ibd-study/)
- [Development of the Lémann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease](https://scholariq.org/papers/development-of-the-lemann-index-to-assess-digestive-tract-damage-in-patients/)
- [ECCO Guidelines on Inflammatory Bowel Disease and Malignancies](https://scholariq.org/papers/ecco-guidelines-on-inflammatory-bowel-disease-and-malignancies/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-surgical-treatment-2/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)

## Researcher university

- [Azienda Ospedaliera San Camillo-Forlanini](https://scholariq.org/institutions/azienda-ospedaliera-san-camillo-forlanini/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.